Work

Overview of neurofilament light chain in mental disorders

Year: 2026
Type: article
Abstract: Neurofilament light chain (NfL), released following neuroaxonal damage, serves as a biomarker in neurological diseases and shows potential in mental disorders. This narrative review aims to clarify the current research status of NfL in five mental disorders, namely depression, bipolar disorder, schizophrenia, substance use disorder, and anxiety, as well as in electroconvulsive therapy. We conducted a literature review using articles from PubMed, EMBASE, Google Scholar, and Web of Science databases. In depression, most population-based studies supported positive associations between NfL and depressive symptoms, whereas clinical findings were mixed. For bipolar disorder, most studies reported elevated NfL levels compared to healthy controls. In schizophrenia, however, more studies found no significant elevation compared with healthy controls. For substance use disorder, studies reported dynamic changes in NfL across withdrawal stages, with most evidence derived from alcohol dependence. The only study on anxiety disorder lacked patient-control comparisons. Studies on electroconvulsive therapy consistently reported no significant changes in NfL after treatment. Overall, research on NfL in mental disorders remains at a preliminary stage and requires further validation, as well as mechanistic and longitudinal studies.
Language: English
Field: Medicine
Open Access status: diamond
OpenAlex ID: W7213462607
FWCI:
Cites: 85
Cited by:
Related to: 10